Skip to main content
Caplight Logo









Etisense

Etisense

Private
LyonHealthcare & Life Scienceshttps://etisense.com/

Last Round

Seed

Jul 16, 2020

Total Funding Raised

$510,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Etisense is a biomedical engineering company that develops and commercializes non-invasive physiological monitoring instruments for preclinical research.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Medical Devices, Drug Discovery, Health IoT, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS, Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

preclinical researchnon-invasive telemetryanimal monitoringsafety pharmacologywearable biosensorslab animal techtoxicology studiesphysiological monitoringdrug discoveryin vivo monitoring3Rs principlesanimal welfarebiotech equipmentmedtechhealth iot

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Etisense Comparables

Compare Etisense with similar companies based on industry and business-model similarity.

Etisense comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
emka TECHNOLOGIES
77%
Kent Scientific Corporation
77%
Harvard Bioscience
75%

Etisense Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 16, 2020
GrantJul 4, 2019
AcceleratorApr 1, 2018

Key People

Founding team and executive leadership

Charles Eynard

Co-Founder - CTO

Founding Team

Timothé Flenet

CEO - Scientific Director

Executive Team

Etisense Investors

Notable investors and investment history

Etisense investors
InvestorRounds
Health Angels Rhône-AlpesSeed
Angels SantéSeed
LinksiumAccelerator
BpifranceGrant
Institut Carnot LSIAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 79% MoM.

  • Apr 7, 2026

    Monthly visitors increased 343% MoM.

Recent news

Latest coverage and updates

  • attends_eventJun 22, 2026

    Etisense Sas attends event 3rd International Marmoset Congress.

Etisense Filings

Explore SEC and related filing metadata, where available.

Etisense filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Etisense's valuation, stock price, and market status.

Is Etisense a public or private company?

Etisense is a private company.

What is the current stock price of Etisense?

Etisense is a private company with no public stock price. No recent secondary market data is available.

How much is Etisense worth (valuation)?

Valuation information for Etisense is not publicly available.

Can I buy Etisense stock?

Etisense shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Etisense's last funding round?

Etisense's most recent funding round was Seed on July 16, 2020.

Who are the main investors in Etisense?

Key investors in Etisense include Health Angels Rhône-Alpes, Angels Santé, Linksium, Bpifrance, Institut Carnot LSI.

Will Etisense IPO soon?

No public IPO plans have been announced for Etisense.

How can I track Etisense secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Etisense's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLyon
Employee Range10
Year Founded2018
Last FundingJul 16, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?